Lille, Belgium

Freddy F Vlaeminck


Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 108(Granted Patents)


Location History:

  • Veldstraat, BE (1989)
  • Lille, BE (1990 - 1992)

Company Filing History:


Years Active: 1989-1992

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Freddy F Vlaeminck

Introduction

Freddy F Vlaeminck is a notable inventor based in Lille, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that stimulate gastrointestinal motility. With a total of eight patents to his name, Vlaeminck's work has had a considerable impact on medical treatments.

Latest Patents

Vlaeminck's latest patents include "Substituted N-(3-hydroxy-4-piperidinyl)benzamides" and "Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides." These inventions focus on compounds that possess gastro-intestinal motility stimulating properties. They also encompass their N-oxide forms, pharmaceutically acceptable acid-addition salts, and methods for treating warm-blooded animals suffering from gastrointestinal motility disorders.

Career Highlights

Throughout his career, Vlaeminck has worked with prominent companies in the pharmaceutical industry, including Janssen Pharmaceutica. His expertise in the field has allowed him to develop innovative solutions that address critical health issues related to gastrointestinal function.

Collaborations

Vlaeminck has collaborated with esteemed colleagues such as Georges H Van Daele and Michel A De Cleyn. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Freddy F Vlaeminck's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through scientific research. His patents reflect a deep understanding of gastrointestinal motility and its implications for treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…